IC
TAK icon

IEQ Capital’s Takeda Pharmaceutical TAK Stock Holding History

IEQ Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Sell
99,417
-4,899
-5% -$81.1K 0.01% 903
2026
Q1 		$1.93M Buy
104,316
+13,206
+14% +$232K 0.01% 778
2025
Q4 		$1.42M Buy
91,110
+2,740
+3% +$39.2K ﹤0.01% 904
2025
Q3 		$1.29M Buy
88,370
+46,868
+113% +$696K ﹤0.01% 916
2025
Q2 		$642K Buy
41,502
+19,280
+87% +$285K ﹤0.01% 1043
2025
Q1 		$330K Buy
22,222
+981
+5% +$13.7K ﹤0.01% 1146
2024
Q4 		$281K Buy
21,241
+9,874
+87% +$136K ﹤0.01% 1053
2024
Q3 		$162K Buy
11,367
+438
+4% +$6.21K ﹤0.01% 1077
2024
Q2 		$141K Buy
+10,929
New +$145K ﹤0.01% 936

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

IEQ Capital's TAK Position: Q2 2026 in Review

IEQ Capital reduced its Takeda Pharmaceutical (TAK) stake by 4.7% in Q2 2026, selling an estimated $81.1K and leaving 99,417 shares worth $1.59M. The position accounts for 0.01% of the portfolio, ranked #903.

IEQ Capital first reported a position in TAK in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.93M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • IEQ Capital held 99,417 shares of Takeda Pharmaceutical worth $1.59M as of Q2 2026.
  • IEQ Capital sold 4,899 Takeda Pharmaceutical shares in Q2 2026, an estimated $81.1K.
  • Takeda Pharmaceutical made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #903 holding.
  • IEQ Capital first reported a position in Takeda Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • IEQ Capital's Takeda Pharmaceutical position peaked at $1.93M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.